A detailed history of Gqg Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Gqg Partners LLC holds 3,678 shares of NVS stock, worth $356,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,678
Previous 2,475 48.61%
Holding current value
$356,140
Previous $263,000 60.84%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$106.13 - $120.89 $127,674 - $145,430
1,203 Added 48.61%
3,678 $423,000
Q2 2024

Aug 12, 2024

BUY
$92.57 - $107.37 $229,110 - $265,740
2,475 New
2,475 $263,000
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $998,317 - $1.22 Million
-13,214 Reduced 84.38%
2,446 $221,000
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $102,904 - $119,812
1,278 Added 8.89%
15,660 $1.32 Million
Q1 2022

May 13, 2022

BUY
$80.11 - $90.62 $93,568 - $105,844
1,168 Added 8.84%
14,382 $1.26 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $219,334 - $242,533
-2,752 Reduced 17.24%
13,214 $1.16 Million
Q1 2021

May 14, 2021

BUY
$83.5 - $98.47 $229,792 - $270,989
2,752 Added 20.83%
15,966 $1.37 Million
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $1.03 Million - $1.25 Million
13,214 New
13,214 $1.25 Million
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $313,916 - $439,802
-4,442 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $374,682 - $423,633
4,442 New
4,442 $421,000
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $344,739 - $394,308
-4,577 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $123,675 - $137,711
-1,679 Reduced 26.84%
4,577 $351,000
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $406,076 - $458,940
6,256 New
6,256 $473,000
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $213,985 - $255,816
-3,040 Closed
0 $0
Q3 2017

Nov 13, 2017

SELL
$74.14 - $77.27 $100,830 - $105,087
-1,360 Reduced 30.91%
3,040 $261,000
Q2 2017

Mar 19, 2018

BUY
N/A
4,400
4,400 $367,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $208B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gqg Partners LLC Portfolio

Follow Gqg Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gqg Partners LLC with notifications on news.